Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Current Liabilities (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Total Current Liabilities data on record, last reported at $100.1 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 29.23% year-over-year to $100.1 million; the TTM value through Dec 2025 reached $100.1 million, up 29.23%, while the annual FY2025 figure was $100.1 million, 29.23% up from the prior year.
  • Total Current Liabilities reached $100.1 million in Q4 2025 per ORGO's latest filing, up from $90.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $100.1 million in Q4 2025 and bottomed at $65.1 million in Q1 2025.
  • Average Total Current Liabilities over 5 years is $80.5 million, with a median of $80.8 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 34.99% in 2021, then fell 23.2% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $82.7 million in 2021, then fell by 9.29% to $75.0 million in 2022, then grew by 7.31% to $80.5 million in 2023, then dropped by 3.77% to $77.5 million in 2024, then increased by 29.23% to $100.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $100.1 million in Q4 2025, $90.3 million in Q3 2025, and $65.8 million in Q2 2025.